Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071807 · ClinicalTrials.gov registry record · Phase 2
Cardiometabolic Effects of Pecans as a Snack
A Phase 2 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 138
- Enrollment target
NCT05071807 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 138 participants.
The verdict
NCT05071807, a Phase 2 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 138 participants
- Enrollment target
Study Summary
A randomized, 2-arm, parallel trial will be conducted to examine the effect of pecans on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control.
Interventions
- OTHER Usual Care
- DRUG Pecans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2024-03-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05071807
The ClinicalTrials.gov registry entry for NCT05071807 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05071807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05071807 about?
NCT05071807 is a clinical study titled "Cardiometabolic Effects of Pecans as a Snack". A randomized, 2-arm, parallel trial will be conducted to examine the effect of pecans on markers of peripheral vascular health, lipids and lipoproteins, blood pressure, and glycemic control.
What is the current status of trial NCT05071807?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 138 participants. The study started on 2022-08-15. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05071807?
The interventions under investigation include: Usual Care (OTHER), Pecans (DRUG).
Who is sponsoring clinical trial NCT05071807?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.